Yelin Lapidot Holdings Management Ltd.
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1590495
Tel Aviv, L3
Position in TEVA
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$10,683,684
-$1,659,995 QoQ
Shares Held
354,704
-10.3% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
2.75%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Yelin Lapidot Holdings Management Ltd. holds $12,509,484 across 2 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (85.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
354,704 | $10,683,684 | |
| 2 | PRGO |
PERRIGO Co plc
|
170,000 | $1,825,800 |
All Filings in TEVA
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,683,684 | 354,704 | Shares | Defined | 2026-04-22 | |
| 2025-12-31 | $12,343,679 | 395,504 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $7,989,180 | 395,504 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $6,628,647 | 395,504 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $6,078,896 | 395,504 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $8,716,908 | 395,504 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $9,405,430 | 521,944 | Shares | Defined | 2024-10-15 | |
| 2024-06-30 | $8,778,315 | 540,204 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $7,622,278 | 540,204 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $5,639,729 | 540,204 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $5,510,080 | 540,204 | Shares | Defined | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||